Evidence map›Paper›PMID 35193616›Full record

ArticleGlobalization and health2022

Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.

Sudhan Rackimuthu, Kapil Narain, Arush Lal, Faisal A Nawaz, Parvathy Mohanan, Mohammad Yasir Essar, Henry Charles Ashworth

Open access · goldAbstract read
In one paragraph

Article in Globalization and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Access to the COVID-19 Vaccine.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 7 countries.

Sudhan RackimuthuFather Muller Medical College, Mangalore, Karnataka, India.ORCID 0000-0002-9539-8562
Kapil NarainNelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Arush LalDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Faisal A NawazCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Parvathy MohananFaculty of Medicine, Medical University Sofia, Sofia, Bulgaria.
Mohammad Yasir EssarKabul University of Medical Sciences, Kabul, Afghanistan. yasir.essar@gmail.com.
Henry Charles AshworthHarvard Medical School, Boston, MA, USA.
Father Muller Medical College Hospital · INHarvard University · USKabul University · AFLondon School of Economics and Political Science · GBMedical University of Sofia · BGMohammed Bin Rashid University of Medicine and Health Sciences · AEUniversity of KwaZulu-Natal · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith large swathes of the world's population-majority clustered in low- and middle-income countries-still yet to receive the minimum of two doses of the COVID-19 vaccine; The need to address the failures of international solidarity to equitably distribute COVID-19 vaccines is now more urgent than ever to help curb the pandemic and prevent future variants. However, many high-income countries have adopted a "me first" approach, proceeding to offer COVID-19 booster doses to their entire populations, including those at least risk of severe illness, whilst the rest of the world is left unvaccinated or partially vaccinated with one dose for even their most vulnerable communities. MAIN BODY: COVID-19 vaccine inequity places the health of the global population at risk and exacerbates socio-economic repercussions, especially in low- and middle-income countries. Initiatives launched to combat vaccine inequity such as the Fair Allocation Framework for the COVID-19 Vaccines (COVAX) have been unsuccessful as several governments, primarily from high-income countries, have scaled down their contributions to the initiative. Furthermore, COVAX has not seriously engaged with the Access to COVID-19 Tools (ACT) Health Systems Connector, as was originally intended, leading to crucial health systems components critical to vaccine delivery to be overlooked. Several strategies can be employed to help achieve the desired global immunization goals, such as Intellectual Property waivers, increased donations, and activation of new COVID-19 vaccine manufacturing hubs. In addition, continued advocacy for vaccine equity by all involved and affected stakeholders, as well as critical amendments to existing or upcoming legislation and funding mechanisms will help address the shortcomings of current inequitable vaccine distribution.

conclusionsGlobal solidarity and collective action through pandemic governance mechanisms are urgently needed to ensure vaccine equity. These interventions are vital to rapidly mitigate ongoing health and humanitarian crises and ultimately curb the pandemic, sooner rather than later.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesGlobal HealthHumansSARS-CoV-2COVID-19 VaccinesVaccinesCOVID-19COVID-19 vaccine boosterGlobal healthHealth equity

Identifiers

PMID35193616
PMCPMC8862404
OpenAlexW4213063456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.